This project produces standalone, highly-redistributable builds of Python. See the docs in docs/ or online at https://gregoryszorc.com/docs/python-build-standalone/main/.

The company is facing pressure on two fronts—the government and a host of new AI-powered search rivals. It has the capacity to meet both challenges and continue to prosper.

Las Vegas (Reuters) -Alphabet said on Wednesday it was still committed to spending some $75 billion this year to build out data center capacity despite turmoil over U.S. tariffs and sought to ...

Alphabet stock fell 22.1% in Q1 2025 following disappointing revenue and uncomfortably generous capital spending plans. Some investors see Alphabet's $75 billion capital expense budget as a threat ...

Building on their longstanding partnership, Google, Alphabet and NVIDIA announced new initiatives ... together to optimize popular open-source frameworks like JAX, a popular Python library for machine ...

After weakness following the company’s fourth-quarter earnings, Alphabet’s GOOG stock continues to face downward pressure as the markets reel from a spectacular rout catalyzed by the ...

Alphabet (GOOGL) closed at $157.04 in the latest trading session, marking a -0.02% move from the prior day. The stock trailed the S&P 500, which registered a daily gain of 0.67%. Meanwhile, the ...

It will receive follow-on capital from existing backer Alphabet. The London-based company’s goal is an ambitious one – to “solve all disease,” according to the Isomorphic Labs site.

Isomorphic Labs Inc., a healthcare startup that spun out of Alphabet Inc. in 2021, today announced that it has closed a $600 million funding round. OpenAI backer Thrive Capital led the investment.

And with Alphabet Inc.’s stock now 25% off its highs, a Melius Research analyst is exploring that question with a bit more intensity. Melius’s Ben Reitzes asked Monday whether Google is the ...

Isomorphic Labs raised $600 million in its first external funding round to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.

Isomorphic Labs, the Alphabet Inc.-owned company that uses artificial intelligence to discover drugs, has raised $600 million, the first time it’s taken in external funding. The round was led by ...